Avita Medical | 1811094D - Gross Profit On Sales

Stock Price
1.09
Daily Change
-0.05 -3.96%
Monthly
4.31%
Yearly
-62.67%
Q1 Forecast
1.19

Avita Medical reported AUD14.95M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Celltrion KRW 626.11B 81.75B Sep/2025
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Cochlear AUD 426.8M 454.9M Jun/2025
CSL USD 1.75B 2.53B Jun/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 14.54B 1.5B Jun/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Knight Therapeutics CAD 44.83M 9.96M Jun/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Mayne Pharma AUD 86.13M 18.92M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Nanosonics AUD 81.96M 8.51M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Pacific Edge NZD 5.2M 1.75M Jun/2024
Paradigm Biopharmaceuticals AUD -9K 423.94K Jun/2025
Pharma Mar EUR 33.36M 20.25M Sep/2025
Polynovo AUD 23.26M 22.74M Jun/2024
PYC Therapeutics AUD 5.83M 750K Jun/2025
Qiagen NV USD 344.8M 10.51M Sep/2025
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
ResMed USD 886.53M 65.71M Dec/2025
Sartorius EUR 393.2M 23M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Telix Pharmaceuticals AUD 129.12M 96.58M Dec/2024
Tilray USD 67.63M 15.62M Mar/2025
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025